PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 72.00
-3.00 (-4.00%)
At close: Feb 27, 2026
IDX:MEDS Market Cap
IDX:MEDS has a market cap or net worth of 112.5 billion as of February 27, 2026. Its market cap has increased by 44.00% in one year.
Market Cap
112.50B
Enterprise Value
119.05B
Revenue
4.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
72.00
Market Cap Chart
Since August 10, 2022, IDX:MEDS's market cap has decreased from 262.50B to 112.50B, a decrease of -57.14%. That is a compound annual growth rate of -21.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 112.50B | 1.41% |
| Dec 30, 2025 | 110.94B | 42.00% |
| Dec 30, 2024 | 78.13B | -26.47% |
| Dec 29, 2023 | 106.25B | -49.25% |
| Dec 30, 2022 | 209.38B | -20.24% |
| Aug 10, 2022 | 262.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 192.31T |
| PT Kalbe Farma Tbk. | 48.71T |
| PT Soho Global Health Tbk | 36.17T |
| PT Siloam International Hospitals Tbk | 35.33T |
| PT Indofarma Tbk | 390.51B |
| PT Diagnos Laboratorium Utama Tbk | 387.50B |
| PT Royal Prima Tbk | 287.16B |
| PT Millennium Pharmacon International Tbk | 252.25B |